首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: A concordance and validation study
【24h】

The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: A concordance and validation study

机译:吲哚菁绿方法等同于99mTc标记的放射性示踪剂方法,用于识别乳腺癌的前哨淋巴结:一致性和验证性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Aims The aim of this study was to assess concordance between the indocyanine green (ICG) method and 99mTc-radiotracer method to identify the sentinel node (SN) in breast cancer. Evidence supports the feasibility and efficacy of the ICG to identify the SN, however this method has not been prospectively compared with the gold-standard radiotracer method in terms of SN detection rate. Methods Between June 2011 and January 2013, 134 women with clinically node-negative early breast cancer received subdermal/peritumoral injection of 99mTc-labeled tracer for lymphoscintigraphy, followed by intraoperative injection of ICG for fluorescence detection of SNs using an exciting light source combined with a camera. In all patients, SNs were first identified by the fluorescence method (ICG-positive) and removed. A gamma ray-detecting probe was then used to determine whether ICG-positive SNs were hot (99mTc-positive) and to identify and remove any 99mTc-positive (ICG-negative) SNs remaining in the axilla. The study was powered to perform an equivalence analysis. Results The 134 patients provided 246 SNs, detected by one or both methods. 1, 2 and 3 SNs, respectively, were detected, removed and examined in 70 (52.2%), 39 (29.1%) and 17 (12.7%) patients; 4-10 SNs were detected and examined in the remaining 8 patients. The two methods were concordant for 230/246 (93.5%) SNs and discordant for 16 (6.5%) SNs. The ICG method detected 99.6% of all SNs. Conclusions Fluorescent lymphangiography with ICG allows easy identification of axillary SNs, at a frequency not inferior to that of radiotracer, and can be used alone to reliably identify SNs.
机译:目的这项研究的目的是评估吲哚菁绿(ICG)方法与99mTc-放射性示踪剂方法之间的一致性,以鉴定乳腺癌的前哨淋巴结(SN)。有证据支持ICG识别SN的可行性和有效性,但是就SN检测率而言,尚未将该方法与金标准放射性示踪剂方法进行前瞻性比较。方法在2011年6月至2013年1月之间,对134例临床淋巴结阴性的早期乳腺癌女性进行皮下/腹腔注射99mTc标记的示踪剂进行淋巴显像,然后术中注射ICG进行荧光检测,使用激发光源和SN相机。在所有患者中,首先通过荧光方法(ICG阳性)鉴定并去除SN。然后使用伽马射线探测探针确定ICG阳性SN是否很热(99mTc阳性),并识别并去除残留在腋窝中的任何99mTc阳性(ICG阴性)SN。该研究能够进行等效分析。结果134例患者通过一种或两种方法检测到246个SN。在70例(52.2%),39例(29.1%)和17例(12.7%)的患者中分别检测到了1、2和3个SN;在其余8例患者中检测到4-10个SN。两种方法对230/246(93.5%)SN一致,对16(6.5%)SN不一致。 ICG方法检测到所有SN的99.6%。结论结合ICG的荧光淋巴血管造影术可以轻松识别腋窝SN,其频率不低于放射性示踪剂,并且可以单独用于可靠地识别SN。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号